There are many drivers to intensify the manufacturing of vaccines. The emergence of SARS-
CoV-2 has only added to them. Since the pandemic began, we have been seeing an …

Biomanufacturing has evolved into a remarkably dynamic discipline. Considering new
product types and applications, new manufacturing processes and platforms, and new …

In the previous chapter, general aspects of cell culture-based virus production were
presented. Increasing world population, pandemic threats, high costs, and new applications …

There are many drivers to intensify the manufacturing of a biological product. Advances are
occurring throughout the biomanufacturing arena, from process development techniques to …

Major efforts are under way to develop new, high-efficiency, cell-based expression systems
and flexible low-cost biomanufacturing platforms for biotherapeutics and vaccines to …

Every year, millions of people are infected by the influenza virus around the world, which
results in more than half a million deaths, particularly among the more vulnerable …

Vaccine Manufacturing and Production is an invaluable reference on how to produce a
vaccine-from beginning to end-addressing all classes of vaccines from a processing …

Vaccine Manufacturing and Production is an invaluable reference on how to produce a
vaccine-from beginning to end-addressing all classes of vaccines from a processing …

Emerging, re-emerging and zoonotic viral pathogens represent a serious threat to human
health, resulting in morbidity, mortality and potentially economic instability at a global scale …

Vaccine production and supply need a paradigm change - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …